无功能垂体微腺瘤:影像随访间隔可否延长?大型单中心队列研究
该回顾性单中心队列研究纳入2006-2021年保守治疗的无功能垂体微腺瘤(NFPmAs)患者347例,评估其临床表现与自然史。中位影像随访29个月期间仅8.1%肿瘤增大,生长发生率2.1/100人年,且生长轻微、未伴新发垂体功能减退或视野缺损,提示自然史总体良性,初始MRI随访间隔可延长至3年。
要点
- NFPmAs自然史总体良性,中位随访29个月仅8.1%增大。
- 肿瘤生长轻微,未伴随新发垂体功能减退或视野缺损。
- 无占位症状及新发垂体功能减退者,初始MRI随访可延至3年。
核心结论
- NFPmAs自然史总体良性,初始MRI随访间隔可延长至3年,除非病变靠近视交叉、有令人担忧的占位症状或新发垂体功能减退。
研究设计与样本
- 回顾性单中心队列研究,纳入2006-2021年保守治疗的无功能垂体微腺瘤患者347例。
- 通过垂体或脑MRI评估肿瘤大小,以变化≥2 mm为显著变化。
主要发现
- 头痛(78.4%)和乏力(70.0%)常见,但无占位效应或显著垂体功能减退证据。
- 基线垂体功能减退罕见,性腺功能减退最常见(5.1%)。
- 中位影像随访29个月(范围3-154),8.1%的NFPmAs增大。
- 生长发生率为2.1/100人年,平均至生长时间38.1个月(SD±36.4),中位24.5个月(IQR 12.0-70.8)。
- 肿瘤生长轻微,未伴随新发垂体功能减退或视野缺损。
关键数值与推荐
- 肿瘤大小变化≥2 mm(由垂体或脑MRI确定)视为显著变化。
- 初始MRI随访时间线可延长至3年,除非病变靠近视交叉、有令人担忧的占位症状或新发垂体功能减退。
临床怎么用
- 对于无占位症状及新发垂体功能减退的NFPmAs患者,可考虑将初始MRI随访间隔延长至3年。
- 若病变靠近视交叉、出现令人担忧的占位症状或新发垂体功能减退,则不应延长随访间隔。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Characterization of the clinical features and natural history of nonfunctioning pituitary microadenomas (NFPmAs) is limited by heterogeneous and small-scale studies. OBJECTIVE: To characterize the clinical presentation and natural history of NFPmAs and evaluate if imaging follow-up interval can be extended. METHODS: Retrospective single-center cohort study (years 2006-2021) of conservatively managed patients with NFPmAs. Initial symptoms, pituitary function, and tumor size were assessed. A change in NFPmA size ≥2 mm, as determined by pituitary or brain magnetic resonance imaging (MRI), was considered significant. RESULTS: There were 347 patients in the study cohort. Headache (78.4%) and fatigue (70.0%) were commonly reported despite no evidence of mass effect or significant pituitary hypofunction. Pituitary deficiencies at baseline were rare, with hypogonadism being most common (5.1%). During a median imaging follow-up period of 29 months (range 3-154), 8.1% of NFPmAs grew. Growth incidence was 2.1 per 100 person-years with a mean and median time to growth of 38.1 (SD ± 36.4) and 24.5 (interquartile range 12.0-70.8) months, respectively. Tumor growth was mild and not associated with new pituitary deficiencies or visual deficits. CONCLUSION: These data indicate that the natural history of NFPmAs is overall benign. Consequently, we propose that the initial MRI follow-up timeline for NFPmAs can be extended up to 3 years unless a lesion is close to the optic chiasm, there are worrisome mass effect symptoms, or new pituitary deficiencies.
引用
- Han AJ, Varlamov EV, Fleseriu M, et al. Nonfunctioning Pituitary Microadenomas: Should Imaging Interval be Extended? A Large Single-center Cohort Study. J Clin Endocrinol Metab. 2022. PMID: 34648635. doi:10.1210/clinem/dgab748
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。